Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine and Memory Processes (SID2)
NCT05318248Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, double-blind trial of Clonidine Lauriad (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Working Memory (n-back task) at 11 minutes, Recognition Memory (word list learning) at 25 minutes and 1 more. Started Mar 2022; status: completed.
02
Drugs
Clonidine Lauriad
Beyond the preview
Go deeper on NCT05318248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05318248.